MLchartDataset catalogue

Hexamethylene bisacetamide

Term · Oncology and biomedicine · MLC-T-ONC-014115

A hybrid polar-planar compound with potential antineoplastic activity that induces terminal differentiation, inhibits cell growth, and causes apoptosis in several tumor cell lines. Its precise mechanism of action is unknown.

Table 1. Record
IdentifierMLC-T-ONC-014115
FieldOncology and biomedicine
AbbreviationHMBA
Synonymshexamethylenebisacetamide; hexamethylenediacetamide
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-014115",
  "term": "Hexamethylene bisacetamide",
  "field": "Oncology and biomedicine",
  "definition": "A hybrid polar-planar compound with potential antineoplastic activity that induces terminal differentiation, inhibits cell growth, and causes apoptosis in several tumor cell lines. Its precise mechanism of action is unknown.",
  "abbreviation": "HMBA",
  "synonyms": [
    "hexamethylenebisacetamide",
    "hexamethylenediacetamide"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hexamethylene-bisacetamide/"
}

Record 8,475 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.